Amanote Research
Register
Sign In
Enzastaurin Inhibits Tumours Sensitive and Resistant to Anti-Egfr Drugs
British Journal of Cancer
- United Kingdom
doi 10.1038/sj.bjc.6604493
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
July 29, 2008
Authors
T Gelardi
R Caputo
V Damiano
G Daniele
S Pepe
F Ciardiello
M Lahn
R Bianco
G Tortora
Publisher
Springer Science and Business Media LLC
Related search
Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
PLoS Medicine
Biochemistry
Biotechnology
Molecular Biology
Cell Biology
Medicine
Drug-Resistant Tuberculosis and Group 5 Anti-Tuberculosis Drugs
Archives of Pediatric Infectious Diseases
Child Health
Infectious Diseases
Pediatrics
Perinatology
Two Novel Human Anti-ErbB2 Immunoagents Are Active on Trastuzumab-Resistant Tumours
British Journal of Cancer
Cancer Research
Oncology
EZH2 Inhibition Sensitizes BRG1 and EGFR Mutant Lung Tumours to TopoII Inhibitors
Nature
Multidisciplinary
Aberrant HER3 Ligand Heregulin-Expressing Head and Neck Squamous Cell Carcinoma Is Resistant to Anti-Egfr Antibody Cetuximab, but Not Second-Generation EGFR-TKI
Oncogenesis
Cancer Research
Molecular Biology
Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling
PLoS ONE
Multidisciplinary
Biodistribution and Pharmacokinetics ofMad2siRNA-loaded EGFR-targeted Chitosan Nanoparticles in Cisplatin Sensitive and Resistant Lung Cancer Models
Nanomedicine
Development
Materials Science
Nanoscience
Medicine
Bioengineering
Nanotechnology
Biomedical Engineering
Extrapyramidal Reactions to Anti-Inflammatory Drugs.
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-Egfr and Anti-Met Therapies
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
